In This Section

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is the most diagnosed blood cancer in adults. It is characterized by uncontrolled growth of abnormal white blood cells, which accumulate in the bone marrow and interfere with the production of normal blood cells.

Patients with acute myeloid leukemia present symptoms such as fatigue, shortness of breath, easy bruising, and frequent infections. Treatment for acute myeloid leukemia typically involves chemotherapy, targeted therapy, and sometimes allogeneic stem cell transplantation depending on the patient’s age, disease characteristics, comorbidities, and overall health. Despite recent advancements in treatment, acute myeloid leukemia can be aggressive and remains difficult to treat.

Explore ACCC’s portfolio to discover educational resources for improving AML care today.

Achieving & Maintaining Better Outcomes for Patients with Acute Myeloid Leukemia Project

Improving quality of care to optimize outcomes and ensuring a smooth continuation of care from academic to community cancer centers is critically important for patients with acute myeloid leukemia. Access actionable resources ACCC has developed to address current care coordination barriers now.

Addressing Disparities in Access to Care for Patients with Acute Myeloid Leukemia

Older patients diagnosed with acute myeloid leukemia face many barriers to accessing care due to social determinants of health. This education program explores best practices to mitigate disparities in care and improve outcomes for these patients.